Cognitive and noncognitive symptoms in dementia patients: Relationship to cortisol and dehydroepiandrosterone

International Psychogeriatrics

Volumn 10, Issue 1, 1998, Pages 85-96

  Miller, Terry P ^a   Taylor, Joy ^a   Rogerson, Stephanie ^a   Mauricio, Maritess ^a   Kennedy, Quinn ^a   Schatzberg, Alan ^a   Tinklenberg, Jared ^a   Yesavage, Jerome ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; IODINE 125; PRASTERONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; DEMENTIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; MALE; RADIOIMMUNOASSAY; RATING SCALE; SYMPTOM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; BIOLOGICAL MARKERS; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IODINE RADIOISOTOPES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROBEHAVIORAL MANIFESTATIONS; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX;

EID: 0031800220     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610298005171     Document Type: Article

References (44)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed.-rev.). Washington, DC: Author.
2. Balldin, J., Blennow, K., Brane, G., Gottfries, C. G., Karlsson, I., et al. (1994). Relationship between mental impairment and HPA axis activity in dementia disorders. Dementia, 5, 252-256.
3. Bilikiewicz, A., & Bidzan, L. (1990). Dependence on serum cortisol level or the severity of intellectual impairment in primary degenerative dementias. Psychiatria Polska, 24, 2-7.
4. Davous, P., Roudier, M., Piketty, M. L., Abramowitz, C, & Lamour, Y. (1988). Pharmacological modulation of cortisol secretion and dexamethasone suppression in Alzheimer's disease. Biological Psychiatry, 23, 13-24.
5. Deshmukh, V. D., & Deshmukh, S. V. (1990). Stress-adaptation failure hypothesis of Alzheimer's disease. Medical Hypotheses, 32, 293-295.
6. Dodt, C., Dittmann, J., Hruby, J., SpathSchwalbe, E., Born, J., et al. (1991). Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type [see comments]. Journal of Clinical Endocrinology and Metabolism, 72, 272-276.
7. Ferrier, I. N., Pascual, J., Charlton, B. G., Wright, C., Leake, A., et al. (1988). Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biological Psychiatry, 23, 252-260.
8. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
9. Gierl, B., Groves, L., & Lazarus, L. W. (1987). Use of the dexamethasone suppression test with depressed and demented elderly. Journal of the American Geriatrics Society, 35, 115-120.
10. Gurevich, D., Siegel, B., Dumlao, M., Perl, E., Chaitin, P., et al. (1990). HPA axis responsivity to dexamethasone and cognitive impairment in dementia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14, 297-308.
11. Gurevich, D., Siegel, B., Dumlao, M. S., Perl, E., Chaitin, P., et al. (1989). The relationship between cognitive impairment, plasma cortisol levels, and HPA responsibility to dexamethasone in dementia. Progress in Clinical and Biological Research, 317, 175-187.
12. Halbreich, U., Asnis, G. M., Shindledecker, M. A., Zumoff, B., & Nathan, R. S. (1985). Cortisol secretion in endogenous depression. I. Basal plasma levels. Archives of General Psychiatry, 42, 904-908.
13. Hatzinger, M., Z'Brun, A., Hemmeter, U., Seifritz, E., Baumann, F., et al. (1995). Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiology of Aging, 16, 205-209.
14. Hornsby, P. J. (1995). Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline. Annals of the New York Academy of Sciences, 774, 29-46.
15. Hoyer, S., Henneberg, N., Knapp, S., Lannert, H., & Martin, E. (1996). Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Annals of the New York Academy of Sciences, 777, 374-379.
16. Leake, A., Charlton, B. G., Lowry, P. J., Jackson, S., Fairbairn, A., et al. (1990). Plasma N-POMC, ACTH and cortisol concentrations in a psychogeriatric population. British Journal of Psychiatry, 156, 676-679.
17. Legrain, S., Berr, C., Frenoy, N., Gourlet, V., Debuire, B., et al. (1995). Dehydroepiandrosterone sulfate in a long-term care population. Gerontology, 41, 343-351.
18. Lesch, K. P., Ihl, R., Frolich, L., Rupprecht, R., Muller, U., et al. (1990). Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease. Psychiatry Research, 33, 107-112.
19. Lupien, S., Lecours, A. R., Lussier, I., Schwartz, G., Nair, N. P., al. (1994). Basal cortisol levels and cognitive deficits in human aging. Journal of Neuroscience, 14(5, Pt. 1), 2893-2903.
20. Maeda, K., Tanimoto, K.,Terada, T., Shintani, T., & Kakigi, T. (1991). Elevated urinary free cortisol in patients with dementia. Neurobiology of Aging, 12, 161-163.
21. Martignoni, E., Petraglia, F., Costa, A., Bono, G., Genazzani, A. R., et al. (1990a). Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: Changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. Acta Neurologica Scandinavica, 81, 452-456.
22. Martignoni, E., Petraglia, F., Costa, A., Monzani, A., Genazzani, A. R., et al. (1990b). Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type. Journal of Clinical Laboratory Analysis, 4(1), 5-8.
23. Masugi, F., Ogihara, T., Sakaguchi, K., Otsuka, A., Tsuchiya, Y., et al. (1989). High plasma levels of cortisol in patients with senile dementia of the Alzheimer's type. Methods and Findings in Experimental and Clinical Pharmacology, 11, 707-710.
24. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., et al. (1984). Clinical diagnosis of Alzheimer's disease: A report of the NINCDS-ADRDA work-group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
25. Molchan, S. E., Hill, J. L., Mellow, A. M., Lawlor, B. A., Martinez, R., et al. (1990). The dexamethasone suppression test in Alzheimer's disease and major depression: Relationship to dementia severity, depression, and CSF monoamines. International Psychogeriatrics, 2, 99-122.
26. Murphy, B. E. (1991). Steroids and depression. Journal of Steroid Biochemistry and Molecular Biology, 38, 537-559.
27. Nappi, G., Sinforiani, E., Martignoni, E., Petraglia, F., Facchinetti, F., et al. (1988). Aging brain and dementias: Changes in central opioids. European Neurology, 28, 217-220.
28. O'Brien, J. T., Ames, D., Schweitzer, I., Mastwyk, M., & Colman, P. (1996). Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychological Medicine, 26, 7-14.
29. Oxenkrug, G. F., Gurevich, D., Siegel, B., Dumlao, M. S., & Gershon, S. (1989). Correlation between brain-adrenal axis activation and cognitive impairment in Alzheimer's disease: Is there a gender effect? Psychiatry Research, 29, 169-175.
30. Parnetti, L., Mecocci, P., Neri, C., Palazzetti, D., Fiacconi, M., et al. (1990). Neuroendocrine markers in aging brain: Clinical and neurobiological significance of dexamethasone suppression test. Aging Milano, 2, 173-179.
31. Roelandts, F. (1989). A single measurement of adrenocorticotrophic hormone in cerebrospinal fluid is of no value in the diagnosis of dementia. Age and Aging, 18, 337-338.
32. Rothschild, A. J., Benes, F., Hebben, N., Woods, B., Luciana, M., et al. (1989). Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biological Psychiatry, 26, 565-575.
33. Seckl, J. R., French, K. L., O'Donnell, D., Meaney, M. J., Nair, N. P., et al. (1993). Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. Brain Research. Molecular Brain Research, 18, 239-245.
34. Serby, M., Zucker, D., Kaufman, M., Franssen, E., Duvvi, K., et al. (1988). Clinical stages of dementia and the dexamethasone suppression test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 12, 833-836.
35. Siegel, B., Gurevich, D., & Oxenkrug, G. F. (1989). Cognitive impairment and cortisol resistance to dexamethasone suppression in elderly depression. Biological Psychiatry, 25, 229-234.
36. Skare, S., Pew, B., & Dysken, M. (1990). The dexamethasone suppression test in dementia: A review of the literature. Journal of Geriatric Psychiatry and Neurology, 3, 124-138.
37. Suemaru, S., Suemaru, K., Hashimoto, K., Ogasa, T., Hirasawa, R., et al. (1993). Cerebrospinal fluid corticotropin-releasing hormone and ACTH, and peripherally circulating choline-containing phospholipid in senile dementia. Life Sciences, 53, 697-706.
38. Suemaru, S., Hashimoto, K., Ogasa, T., Hirasawa, R., Makino, S., et al. (1991). Cerebrospinal fluid and plasma corticotropin releasing hormone in senile dementia. Life Sciences, 48, 1871-1879.
39. Swaab, D. F., Raadsheer, F. C., Endert, E., Hofman, M. A., Kamphorst, W., et al. (1994). Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. Journal of Neuroendocrinology, 6, 681-687.
40. Tollefson, G. D., Godes, M., Warren, J. B., Haus, E., Luxenberg, M., et al. (1989). Lymphopenia in primary degenerative dementia. Journal of Psychiatric Research, 23, 191-199.
41. Vermeulen, A. (1995). Dehydroepiandrosterone sulfate and aging. Annals of the New York Academy of Sciences, 774, 121-127.
42. Vollhardt, B. R., Alexopoulos, G. S., Young, R. C., Kream, J., & Shamoian, C. A. (1989). Clonidine challenge of cortisol secretion in dementia and geriatric depression. International Psychogeriatrics, 1, 167-175.
43. Wolkowitz, O. M., Reus, V. I., Roberts, E., Manfredi, F., Chan, T., et al. (1995). Antidepressant and cognition-enhancing effects of DHEA in major depression. Annals of the New York Academy of Sciences, 774, 337-339.
44. Yanase, T., Fukahori, M., Taniguchi, S., Nishi, Y., Sakai, Y., et al. (1996). Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocrine Journal, 43, 119-123.